We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Web-delivered Provider Intervention for Tobacco Control (QUIT-PRIMO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00797628
Recruitment Status : Completed
First Posted : November 25, 2008
Last Update Posted : August 28, 2013
Johns Hopkins University
University of Alabama at Birmingham
Information provided by (Responsible Party):
Thomas Houston, University of Massachusetts, Worcester

Brief Summary:
This is a randomized control trial to determine the efficacy of a multi-modal intervention in improving smoking cessation processes of care and patient outcomes in community-based primary care practices. Our Overall Goal is to advance science related to the use and impact of the Internet in health services delivery, specifically smoking cessation, by targeting primary care clinical microsystems. A clinical microsystem is defined as the smallest functional healthcare unit. A clinical microsystem is not simply equivalent to a clinical team of doctors and nurses, but also the panel of patients cared for by the providers and the processes of care that are used.

Condition or disease Intervention/treatment
Smoking Cessation Behavioral: Decide2Quit Behavioral: Smoking Coach

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 174 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Health Services Research
Official Title: QUIT-PRIMO: Web-Delivered Clinical Microsystem Intervention for Tobacco Control
Study Start Date : March 2010
Primary Completion Date : August 2013
Study Completion Date : August 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Information Prescription
Providers will give usual care to patients who smoke and a paper prescription with the name and url of the "Smoking Coach" website. The smoking coach website is a tailored, public health intervention for smoking cessation.
Behavioral: Smoking Coach
Control Patients will be referred by paper prescription to the control- "Smoking Coach" website.
Experimental: QUIT-PRIMO
Providers will give usual care to patients who smoke and then refer patients to the online smoking cessation system electronically.
Behavioral: Decide2Quit
Patient intervention website that includes 1) interactive calculators to assess readiness to quit, symptoms and quit plan, 2) motivational content, and 3) links to other high quality information.

Primary Outcome Measures :
  1. Physician performance on refering patients that smoke cigarettes to the web intervention [ Time Frame: pre-intervention, 6 months, 12 months and 24 months ]
  2. Of the smokers who are referred to the web intervention, the number who go to the site [ Time Frame: preintervention, 6 months, 12 months, 24 months ]
  3. Point prevalence smoking cessation [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Community based primary care practices who have:

    • Internet access in office
    • Sees 4 - 5 smokers per week

Exclusion Criteria:

  • Practices with more than five providers

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00797628

United States, Massachusetts
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655
Sponsors and Collaborators
University of Massachusetts, Worcester
Johns Hopkins University
University of Alabama at Birmingham
Principal Investigator: Thomas K Houston, MD University of Massachusetts, Worcester

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Thomas Houston, Principal Investigator, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier: NCT00797628     History of Changes
Other Study ID Numbers: X071211009
NIH R01CA129091
First Posted: November 25, 2008    Key Record Dates
Last Update Posted: August 28, 2013
Last Verified: August 2013